Tirzepatide

Dual GIP/GLP-1 Agonist

FROM$1080$990/ quarterly

Plan

Choose your cadence. Cancel between cycles

Get started. From $990

Ships in quarterly cycles · cancel between cycles

Important. Eternal Longevity peptides are compounded by a licensed 503A pharmacy and third-party tested. Not a substitute for medical care; do not use if pregnant, nursing, or under 18.

Overview

Tirzepatide activates both GIP and GLP-1 receptors, producing greater weight loss and glycemic control than GLP-1-only agents. Phase 3 SURMOUNT trials show 20–22% mean body-weight reduction at 72 weeks. Titrated slowly to minimize GI side effects.

Best for

Members who need stronger metabolic intervention than GLP-1 alone provides.

Benefits

20–22% mean body-weight reduction
Superior glycemic control vs GLP-1 alone
Reduced visceral fat
Sustained appetite regulation

What's included

12 weeks of compounded Tirzepatide (2.5–15 mg/week SQ, titrated)
Insulin syringes
Alcohol prep pads
Anti-nausea support if needed
Mid-cycle protocol check-in + labs

Specifications

Delivery: Subcutaneous
Cycle length: 12-week cycle
Category: Metabolic
Storage: Refrigerated 2–8°C · use within compounding date
Third-party tested: Yes

Shipping

Cold-chain shipped from our licensed 503A pharmacy in temperature- controlled packaging. Free shipping on every cycle. Tracking available in your portal once your order ships.